Factor X (factor ten) of the coagulation cascade binds to the integrin CD11b/CD18 during inflammation, initiating procoagulant activity on the surface of leukocytes (Altieri, D.C., O. R. Etingin, D. S. Fair, T. K. Brunk, J. E. Geltosky, D. P. Hajjar, and T. S. Edgington. 1991. Science [Wash. DC]. 254:1200-1202). Filamentous hemagglutinin (FHA), an adhesin of Bordetella pertussis also binds to the CD11b/CD18 integrin (Relman D., E. Tuomanen, S. Falkow, D. T. Golenbock, K. Saukkonen, and S. D. Wright. 1990. Cell. 61:1375- 1382). FHA and the CD11b/CD18 binding loops of Factor X share amino acid sequence similarity. FHA peptides similar to Factor X binding loops inhibited 125I-Factor X binding to human neutrophils and prolonged clotting time. In addition, ETKEVDG and its Factor X analogue prevented transendothelial migration of leukocytes in vitro and reduced leukocytosis and blood brain barrier disruption in vivo. Interference with leukocyte migration by a coagulation-based peptide suggests a novel strategy for antiinflammatory therapy.
CITATION STYLE
Rozdzinski, E., Sandros, J., Van Der Flier, M., Young, A., Spellerberg, B., Bhattacharyya, C., … Tuomanen, E. (1995). Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X. Journal of Clinical Investigation, 95(3), 1078–1085. https://doi.org/10.1172/JCI117754
Mendeley helps you to discover research relevant for your work.